Illumina to cut $100M in fiscal 2025 costs

Illumina to cut $100M in costs to cope with China ban
The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.
Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban
Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China barred sales of the company’s gene-sequencing machines. San Diego-based Illumina is lowering its 2025 guidance to $4.
Illumina lowers guidance, cuts spending to mitigate China ban on its gene sequencers
Illumina (NASDAQ:ILMN) on Monday lowered its adjusted profit outlook and cut spending cost for 2025 as the company grapples with Chinese ban on its gene sequencers. Illumina now expects fiscal 2025 non-GAAP diluted EPS of about $4.
China hits Illumina with import ban. What does that mean for the San Diego gene sequencer?
China imposed an import ban on Illumina’s gene sequencers in response to President Trump’s escalating tariffs and trade war
China Bans Illumina Sequencer Imports as Trade Tensions Rise
China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory trade measures in response to the US doubling tariffs on all Chinese goods.
Tariff: China bans imports of Illumina’s gene sequencers from US
China on Tuesday announced a ban on imports of genetic sequencers from the US medical equipment maker Illumina a few minutes after US President Donald
What's Left of Illumina's China Business After Tariff Retaliation: Heard on the Street
Illumina shareholders received a warning shot. In response to President Trump’s initial tariff measures, the Chinese ...
China Targets San Diego Biotech Firm in Broadening Blacklist
In a sign it is willing to go further in responding to President Trump’s tariffs, Beijing blocked more American companies ...
Tariffs, Cut Funding Spur Illumina’s Worst Month in 23 Years
Illumina Inc. investors suffered back-to-back setbacks each week in February, putting the gene-sequencing company on track to ...
U.S. News & World Report10d
China Bans Imports of Illumina's Gene Sequencers Right After Trump Tariff Action
China Bans Imports of Illumina's Gene Sequencers Right After Trump Tariff Action By Andrew Silver SHANGHAI (Reuters) -China announced a ban on Tuesday on imports of genetic sequencers from U.S ...
Illumina lowering 2025 earnings outlook to low end of range, WSJ says
Illumina (ILMN) is reducing its forecast for this year’s financial performance and cutting $100M in spending because China barred sales of its ...